What question did this study set out to answer?

This research aims to evaluate patient-reported satisfaction levels with self-administered ofatumumab compared to other treatments.

April 23, 2026Drugs - Real World Outcomes0 citationsOpen Access

Patient‑Reported Satisfaction in Relapsing-Remitting Multiple Sclerosis: Advantages of At‑Home Self‑Administered Subcutaneous Ofatumumab Versus Other High‑Efficacy Therapies

FPFrancesco Pastore EDEmanuela DomeniconeASL Roma PDPatrizia DellOroNovartis (Italy)

Key Points

This research aims to evaluate patient-reported satisfaction levels with self-administered ofatumumab compared to other treatments.
Compared experiences of patients using self-administered ofatumumab and other high-efficacy therapies.
Analyzed factors influencing therapy selection, including organizational aspects.
Patients reported higher satisfaction with at-home self-administration of ofatumumab.
Highlighting logistical and organizational benefits influenced patient experiences positively.

Abstract

Subcutaneous ofatumumab treatment, a therapy self-administered at home, was associated with more favorable experiences compared to other high-efficacy therapies, highlighting the importance of shared decision making and organizational and logistical factors when selecting therapies for multiple sclerosis.

AIに質問

Bookmark

View Full Paper